The new companies in the Global Digital Health Space raised $ 5 billion in funding dollars Duration The first quarter of this year, marking the highest quarterly investment in the industry since the second quarter of CB Insights. In comparison, the new digital health companies raised only $ 3.7 billion in the first quarter of last year.
Below are three of the most notable findings of the Report on the Financing of Digital Health.
Treatment sizes are getting bigger
In the first quarter of 2025, the average size of digital health financing agreements increased to $ 6.4 million. This is compared to an average offer size or a duration of $ 5.4 million 2024.
This trend repeats the preference of digital health investors “” by new companies on a posterior stage with regulatory milestones and scalable AI platforms, “according to the report.
It is also worth noting that Mega-Contounds, for a total of $ 100 million or more, almost half of the total digital health financing of the first quarter. These 11 megacreshons totaled $ 2.5 billion.
Ai is only getting hotter
The new digital health companies that focus on AI secured eight of the 11 megacresques that occurred in the first quarter.
This includes the $ 600 million round that Isomorphic Labs raised in March, the $ 320 million round that Truveta raised in January, the $ 275 million round that innovated raised the Thitt Thattted million round round.
In general, the new digital health companies focused on AI collected $ 3.6 billion, representing 60% of the total funds of the quarter.
New unicorns are emerging
Six new digital health companies obtained a unicorn status in the first quarter of this year, which means that they reached an assessment of $ 1 billion or more. This is more than the three digital health unicorns that arose the duration of 2024.
Four of the new unicorns that emerged in the first quarter are from the USA: Startup of Clinical Documentation ABRIDGE, AGENTIC AI FIRM AI HYPOCRATIC AI, AI COPILOT PROVIDER OPENENCE AND DATA ANALYTICS COMPANY TRUVETA. The other two unicorns, the full -body exploration developer Neko Health and Drug Discovery Startup Insilico Medicine, are from Sweden and China, respectively.
Photo: Feodora Chiosea, Getty Images